Sector News

Boehringer trims Connecticut workforce as sales suffer

February 17, 2015
Life sciences
Struggling with falling sales, Boehringer Ingelheim is trimming its workforce in Connecticut, which accounts for about 2,700 staffers altogether. 
 
A company spokesperson tells FierceBiotech that less than 5% of its staff at the Ridgefield site is affected by the move, or 2% of the total, but the company is looking to find new positions for some of the people involved in the cutback. 
 
“Boehringer Ingelheim is in the process of rebalancing its workforce in the U.S. to put the company in the best position for future growth,” the company says in a statement. 
 
The 294-acre Ridgefield campus is the site of one of three major R&D centers for Boehringer and serves as its U.S. headquarters. Boehringer announced plans for a $65 million facility to support R&D and production back in 2011.
 
Just weeks ago the company reviewed a possible move to sell its $2.3 billion generics unit and a facility in Columbus, OH. Last fall Boehringer also said it would trim hundreds of jobs in Germany to account for a 5% drop in sales and a reduced forecast for the second half of the year.
 
By John Carroll
 

comments closed

Related News

October 2, 2022

GSK names Julie Brown, a 25-year AstraZeneca veteran, its first woman CFO

Life sciences

Five years ago, GSK made headlines when it hired Emma Walmsley to become the first woman to run a major pharmaceutical company. Now the Big Pharma has brought in another woman to control the company’s finances. Julie Brown will be GSK’s next chief financial officer. Brown, currently the chief operating and financial officer at fashion and beauty brand Burberry Group, is set to replace Iain Mackay.

October 2, 2022

Moderna creates new launch preparation role, poaches Novartis exec as manufacturing lead

Life sciences

Moderna created a new role responsible for “building out the company’s organization to support its growing pipeline.” Starting first thing 2023, Juan Andres, Moderna’s manufacturing head, will step into this new role under the title president of strategic partnerships and enterprise expansion, the company said Thursday.

October 2, 2022

Torrent Pharma to acquire Curatio for $245.16m

Life sciences

The latest takeover is anticipated to boost the presence of Torrent in the dermatology segment. Indian company Torrent Pharmaceuticals has signed a definitive agreement for the complete acquisition of Curatio Healthcare for $245.16m (Rs20bn).